Researcher

Matthew Zirui Tay graduated in Immunology from Brown University, USA, before completing his PhD in 2018 at Duke University, USA, where he studied the effector functions of antibodies against HIV-1. He continued his work as a postdoctoral fellow at the Singapore Immunology Network (SIgN), which focused on antibodies, malaria, and subsequently SARS-CoV-2. In 2020, he moved from SIgN to the newly-founded A*STAR Infectious Diseases Labs (ID Labs), where he currently leads the Antimicrobial Biologics lab as a Principal Investigator. Tay’s current research centres on deciphering the mechanisms through which antibodies fend off infectious diseases. Through a strategy of characterising antibody responses using high-throughput, function-based bioassays, he aims to pioneer novel vaccines and monoclonal antibody therapies for emerging pathogens.